Lower Urinary Tract Syndrome (LUTS)

Overall, LUTS are more common in people with diabetes and are often more pronounced than in non-diabetics. This is described in several review articles/meta-analyses and in specialist urological sources. (PMC)

Why diabetes promotes LUTS

Diabetes can affect the lower urinary tract through several mechanisms:

  • Autonomic neuropathy → impaired bladder control (initially more urgency/OAB-type symptoms, later more of an “underactive bladder” with post-void residual urine). (American Urological Association)
  • Diuretic effects in hyperglycemia (increased urine production) → frequency/pollakiuria and nocturia. (Mechanistically plausible; frequently observed clinically.)
  • Increased risk of infections (UTI) → exacerbation of LUTS (burning, frequency, urgency). (PMC)
  • In men additionally: diabetes is associated with more/severe LUTS in patients with BPH (meta-analysis). (PubMed)

How common is it?

Exact figures vary depending on definition and population. As a rough guide:

  • For OAB (overactive bladder) in diabetes, a recent meta-analysis reports a pooled prevalence of ~30%, with higher odds compared with non-diabetics. (Wiley Online Library)
  • Individual cohorts show substantially higher LUTS rates in diabetics than in controls (e.g., older men). (ICS)

Clinically important in diabetes

In people with diabetes and LUTS, post-void residual/retention and infections should be considered especially, because both increase the risk of complications. Clues include:

  • weak urinary stream + sensation of residual urine
  • recurrent UTIs
  • new overflow incontinence, palpably “full” bladder

LUTS (Lower Urinary Tract Symptoms) refers to a symptom complex of complaints from the lower urinary tract (bladder, urethra; in men additionally the prostate). The term describes symptoms, not a diagnosis.

1. Systematic Classification of LUTS

International standard classification divides LUTS into three main groups:

  1. Storage symptoms

Symptoms during bladder filling:

  • Pollakiuria – frequent voiding of small volumes
  • Nocturia – nighttime urination
  • Urgency – sudden, difficult-to-suppress urge to void
  • Urgency urinary incontinence – involuntary urine loss associated with urgency

Typical in: overactive bladder, age-related bladder changes, neurological causes

  1. Voiding symptoms

Problems during bladder emptying:

  • hesitancy (delayed initiation)
  • weak or intermittent urinary stream
  • straining to void
  • prolonged micturition time

Common in: bladder outlet obstruction (e.g., prostate), urethral stricture

  1. Post-micturition symptoms

Symptoms after voiding:

  • post-void dribbling
  • sensation of incomplete bladder emptying

Suggestive of post-void residual urine or functional disorders

  1. Typical Causes (sex-dependent)

In men

  • benign prostatic hyperplasia (BPH) – most common cause
  • bladder muscle dysfunction
  • prostatitis syndromes
  • neurological diseases

In women

  • overactive bladder
  • pelvic floor weakness
  • recurrent UTIs
  • postmenopausal mucosal changes (e.g., within GSM)
  1. Important Clinical Relationships
  • LUTS increase with age, but are not a “normal” aging change that must simply be accepted
  • Storage and voiding symptoms often occur together
  • Symptom severity does not always correlate with the objective cause (e.g., prostate size)
  1. Diagnostic Approach

Typical elements include:

  • structured symptom questionnaires (e.g., IPSS)
  • urinalysis
  • ultrasound (post-void residual, prostate, bladder)
  • if needed: uroflowmetry or urodynamic testing
  1. Treatment – symptom-oriented

Because LUTS are not a diagnosis, treatment is guided by:

  • the dominant symptom group
  • the underlying cause
  • level of distress/impact on quality of life

Possible approaches:

  • behavioral therapy / bladder training
  • medications (e.g., alpha-blockers, antimuscarinics)
  • pelvic floor therapy
  • surgery (in case of obstruction)

Key takeaway

LUTS describe how a problem presents — not why it exists.

Structured Comparison of LUTS in Men vs. Women (focus on pathophysiology, symptom patterns, and therapeutic implications)

  1. Shared foundation

In both sexes, LUTS describe:

  • storage, voiding, and post-micturition symptoms
  • complaints involving bladder and urethra
  • symptoms, not a diagnosis

However, the causes differ substantially.

  1. Key differences at a glance

Aspect

Men

Women

Main anatomical factor

prostate

pelvic floor & estrogen influence

Most common mechanism

bladder outlet obstruction

storage disorder / functional

Dominant symptoms

voiding > storage

storage > voiding

Age association

strongly age-related

age-related, also postpartum

Hormonal influence

indirect (testosterone)

direct (estrogen)

  1. LUTS in men – typical profile

Key symptoms

  • weak stream
  • hesitancy
  • straining
  • sensation of residual urine
  • nocturia

Pathophysiology

  • mechanical obstruction due to prostate enlargement
  • secondary: detrusor overactivity or underactivity

Important: prostate size ≠ symptom severity

Clinical implication

  • focus on obstruction diagnostics
  • treatment often with alpha-blockers; surgery if needed
  1. LUTS in women – typical profile

Key symptoms

  • urgency
  • frequency
  • urgency incontinence
  • nocturia
  • recurrent urinary complaints

Pathophysiology

  • overactive bladder
  • pelvic floor dysfunction
  • postmenopausal urogenital mucosal changes
  • functional disorders without outlet obstruction

Mechanical obstruction is rare.

Clinical implication

  • focus on storage symptoms
  • pelvic floor therapy, bladder training, anticholinergic/β3-agonist medication
  • possibly local hormone therapy
  1. Post-micturition symptoms – special case
  • Men: usually due to post-void residual urine from obstruction
  • Women: often functional (pelvic floor/coordination)
  1. Diagnostic focus – weighted differently

Diagnostics

Men

Women

Prostate assessment

central

not applicable

Post-void residual measurement

very important

situation-dependent

Pelvic floor assessment

supplementary

central

Urodynamics

selective

more often relevant

Rules of thumb

  • Men: “LUTS = usually an outflow problem”
  • Women: “LUTS = usually a storage problem”
  • Both: take symptoms seriously — don’t dismiss as “just age”

LUTS: Often, but Not Always, Harmless

  1. Common, often chronic — usually benign, but may mask warning signs

Key factors: course, accompanying symptoms, risk profile.

  1. Likely benign / initially observable

Typical features:

  • gradual onset
  • stable over months/years
  • mild to moderate severity
  • no pain
  • no blood in urine
  • no fever
  • normal general condition

Examples:

  • mild nocturia in older age
  • moderate urgency without incontinence
  • weaker stream without residual urine sensation
  • known, stable prostate enlargement

Approach: observe, follow-up, conservative measures.

  1. Needs timely evaluation

“Yellow flags”:

  • newly developed LUTS
  • rapid worsening
  • increasing distress
  • recurrent UTIs
  • lower abdominal/pelvic/back pain
  • unexplained weight loss
  • new incontinence

Goal: identify structural, inflammatory, or functional causes.

  1. Urgent / emergency evaluation

“Red flags”:

  • blood in urine (visible or repeated microscopic hematuria)
  • acute urinary retention
  • fever + voiding symptoms (suspected pyelonephritis/urosepsis)
  • severe pain
  • neurological deficits (numbness, weakness)
  • sudden incontinence + back pain (suspected cauda equina syndrome)

Immediate medical evaluation required.

Differentiating Urgency Incontinence vs. Stress Incontinence

The difference lies in the trigger mechanism, not the amount of urine or “severity”.

Stress incontinence

Involuntary urine loss with increased intra-abdominal pressure without urgency.

Typical sequence:

  1. coughing/sneezing/laughing/lifting
  2. abdominal pressure rises
  3. immediate leakage without warning

Mechanism:

  • urethral sphincter insufficiency
  • pelvic floor weakness
  • rare in men (e.g., after prostate surgery)

Key signs:

  • no urgency
  • usually small volumes
  • situation-dependent

Direct comparison

Feature

Urgency incontinence

Stress incontinence

Urgency

strong

absent

Trigger

spontaneous bladder contraction

pressure increase

Leakage timing

before reaching toilet

during exertion

Volume

variable

usually small

Main problem

bladder control

closure mechanism

Who affected

both sexes

mainly women

Mixed incontinence

Many patients have both forms → mixed incontinence. Treatment follows the dominant symptom.

Key takeaway:

  • Urgency incontinence = bladder too active
  • Stress incontinence = closure too weak

Sex Differences in Incontinence Patterns

Stress incontinence

Women: most common form

  • pelvic floor weakness, urethral hypermobility
  • risks: pregnancy/vaginal birth, postmenopausal estrogen deficiency, obesity
  • typical: leakage with coughing/sneezing/laughing, no urgency

Men: rare

  • usually iatrogenic (after prostate surgery)
  • without surgery: unusual → should be evaluated

Urgency incontinence

Women: very common; increases with age; often linked to OAB, postmenopausal mucosal changes, recurrent UTIs
Men: common but often secondary to bladder outlet obstruction/post-void residual urine

Quick Diagnostic Algorithm (text version)

Step 1: Exclude red flags first (hematuria, fever + urinary symptoms, retention, severe pain, neuro signs, rapidly increasing incontinence)
→ yes: urgent evaluation
→ no: proceed

Step 2: Incontinence yes/no
Step 3: If no incontinence: storage-dominant vs voiding-dominant LUTS
Step 4: If incontinence: urgency vs stress vs mixed
Step 5: Check sex-specific plausibility (men: think obstruction; women: think pelvic floor/functional)
Step 6: Basic work-up: history, urinalysis, post-void residual, symptom score (e.g., IPSS), ultrasound as needed

Therapy Overview (practice-oriented, sex-specific)

Men

  • voiding symptoms (often obstruction): alpha-blockers first line, ± 5-alpha-reductase inhibitors, surgery if complications
  • storage/urgency symptoms: treat obstruction first; then antimuscarinics/β3 agonists only if low residual urine
  • stress incontinence: uncommon; usually post-op → pelvic floor therapy ± surgical options

Women

  • storage/urgency symptoms: bladder training → pelvic floor therapy → antimuscarinics/β3 agonists; postmenopausal: consider local estrogen
  • stress incontinence: pelvic floor training (gold standard), weight reduction, pessary, surgery if needed
  • voiding symptoms: rare → evaluate for functional/neurologic causes

 

References 

Guidelines and standardization documents on LUTS:

  1. EAU Guidelines on management of non-neurogenic male LUTS (2024)
  2. EAU Update on non-neurogenic female LUTS (2024)
  3. AUA/SUFU guideline on diagnosis and treatment of idiopathic OAB (2024)
  4. ICS standardization report on terminology (2002)
  5. AUA guideline on management of LUTS attributed to BPH (2024)